Staff neurologist, Cleveland Clinic; Hôtel-Dieu de France Hospital, Lebanon
Clinical Pearls for MS Management in Everyday Practice
Dr Macaron shares her interpretation of the data and importance of individualizing treatment for patients with multiple sclerosis.
Ozanimod in DMT Naïve vs Experienced Patients with Relapsing Multiple Sclerosis
Dr Gabrielle Macaron reviews data with ozanimod in treatment naïve vs experienced patients with relapsing multiple sclerosis presented at EAN 2022.
Factors Necessitating Treatment Change in Multiple Sclerosis
A multiple sclerosis expert, Dr Gabrielle Macaron, discusses factors that can lead to a change of therapy for patients with multiple sclerosis.
Investigating Disability and Onset Age in NMOSD: Gabrielle Macaron, MD
The neurologist from Cleveland Clinic discussed how her study reinforced previous findings that individuals with early onset neuromyelitis optica spectrum disorders are more likely to experience severe vision loss.
Improving Outcomes in Patients With Early Onset NMOSD: Gabrielle Macaron, MD
The neurologist from Cleveland Clinic discussed how her team found that patients with AO ≤21 years old had worse visual outcomes than those >21 years old.
2 Commerce Drive Cranbury, NJ 08512